Heading to #aao2024 in October? You’re invited to a free dinner #CME/CE program. Not traveling? Come virtually! You’ll learn how to detect the adverse corneal events caused by cancer drugs thanks to Asim Farooq, MD: https://bit.ly/3MqeFSR
Ophthalmology Times’ Post
More Relevant Posts
-
Henlius' pivotal phase 3 clinical study of #serplulimab in squamous non-small-cell #lungcancer graces the cover of the latest issue of Cancer Cell. The first Chinese innovative drug to achieve this honor! Kudos to the investigators and the entire team for pushing the boundaries of innovation in sqNSCLC treatment. Learn more about the study: https://lnkd.in/gjVfdsrP.
-
-
For #TrialTuesday, Aminah Jatoi MD (Mayo Clinic) leads the Alliance A222004 study that compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with advanced cancer. To learn more about the study, visit https://lnkd.in/dnZj9JdG #NCI #NCORP #anorexia
-
-
If you participated in #TriviaTuesday, here is the answer: 1 in 8 men living in the U.S. will have #prostatecancer at some point in their lives. This statistic highlights the importance of knowing the facts! To learn more about the prevalence of prostate cancer and other frequently asked questions, visit: https://bit.ly/4dHxJrv
-
We’ve created this Oral Cancer Screening Guide as a FREE resource to have with you in the operatory🦷🪥 This guide not only shows you the intra and extraoral areas to palpate, but also provides you with clear actions to take in the event a suspicious area is identified📋☑️ Download this free resource by clicking on the link in our bio! #InspiredHygiene #DentalHygieneCoaching #OralCancerAwareness #DSO
-
-
Aspiring Pharmacist || Pharmaceutics || Certified in medical scribing and medical coding || Pharmacovigilence
Got the certificate for the participation in the poster presentation on the grand occasion of ICRAHS Conference 2024 #ICRAHS. I presented a poster on the topic of CANCER THERANOSTICS. #Student #LPU #HealthSciences #Innovative #Pharmacy
-
-
This screening tool from Prevent Cancer Foundation can help you determine which screening tests are appropriate for you as part of your #CancerPrevention strategy. https://lnkd.in/eThQk4ti
-
ASCO 2024: Phase III TNTCRT trial- TNT vs CRT in high-risk rectal cancer with induction CAPOX doublet (as opposed to PRODIGE-23 mFOLFIRINOX triplet) followed by long-course chemoradiation showing improved 3-yr DFS, MFS, and pCR but not OS. https://lnkd.in/gXJnGfX3
-
-
#Cancer research is usually about testing new treatment candidates. But giving an old drug a new purpose is also a way forward and sometimes achieves surprising success. Test your knowledge about these repurposed drugs for cancer with our Eureka Blog #quiz: https://okt.to/KpsLqM
Quiz: Repurposed Drugs for Cancer | Charles River
criver.com
-
Project Manager at the Polymer Therapeutics Laboratory (CIPF), Medical Writer at the Carlos Simon Foundation for Research in Women’s Health, Writer/Editor for Epigenie, and Scientific Manuscript Reviewer
Check out my new blog!
[NEW] The Power of THEMIS – a cfDNA Methylome & Fragmentome Tool for Early Cancer Detection. Why hasn’t this been done before? Our review of this new approach in Nature Communications may give you the power ⚡ https://bit.ly/3AE3TWg #DNA #cellfree #cfDNA #epigenetics #cancerresearch
-
Elijah Anseaume, Peg Achenbach, OD, FAAO, Jack Caperna, MS, Eric Metcalf, MPH